Pierre-Yves Berclaz, Chief Science and Medical Officer at Ferring Pharmaceuticals, stated: "The ADAPT-1 trial results confirm the efficacy and safety of follitropin delta across the full range of ...

Data presented today at the ESHRE congress builds evidence for conventional-based Follicular Stimulating Hormone (FSH) dosing for Rekovelle (follitropin delta); alongside its existing unique algorithm ...

These data build on previous studies which have established an estimated point of clinical correspondence for 10 µg follitropin delta to 150 IU follitropin alfa in this class of medications. 1,2 ...

Discover how certain medications can heighten your risk of heat-related illnesses this summer. Stay safe with expert tips.

Top 10 most expensive prescription drugs in the US by price and by sales volume Following Trump’s price-slashing executive order, a spotlight on which drugs could be affected By Melissa Rudy Fox ...

Ferring Pharmaceuticals presented the initial results from an ongoing Phase 3 trial (NCT05704244) in Japan assessing the efficacy and safety of ADSTILADRIN® (nadofaragene firadenovec-vncg) in ...

Ferring achieved total revenues of €2.3 billion in 2024, an increase of 7% over the previous year at actual exchange rates (AER) and 8% at constant exchange rates (CER). This above market growth ...

Ferring achieved record sales driven by Reproductive Medicine combined with the emergence of Adstiladrin For more information, please contact Carine Julen Senior Manager, Corporate Communications ...

Ferring activates first sites in a three-arm study of ADSTILADRIN as a monotherapy or in combination with chemotherapy or an immune checkpoint inhibitor in high-risk Bacillus Calmette-Guérin (BCG ...

PARSIPPANY, N.J., October 18, 2024--Ferring Pharmaceuticals Illustrates Strong Commitment to Advancing Fertility Care at 2024 ASRM Annual Congress ...

Purvi Tailor, Ferring Pharmaceuticals' VP of HR, says focusing holistically on worker well-being is crucial for retaining top talent in healthcare.